Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
More on Expansion
Providence invests €32m in Net Reviews
GP's growth team is investing via the $2bn Strategic Growth IV fund, closed in Q3
Vostok leads $85m series-B for VOI Technology
Consortium of investors supporting the funding round includes existing and new backers
BGF injects £11m into Molson
BGF previously invested £6.3m in 2018 to fuel growth and potential acquisitions
Consortium invests €32m in Hoppen
New and previous investors back the French provider of IT services for the medical sector
Latest News
Correcting Alpha: fundamental flaws of IRR
Unquote sister publication Private Equity Law Report looks at how sponsors can avoid distorted calculations
Keensight to buy Sogelink from Naxicap
GP returns to the French software provider, which it owned from 2013 to 2016
DIP Capital, Coparion back €5.5m series-A for Acatus
Berlin-based fintech company will use the capital to grow its digital DCM platform
FII-backed Supermercato24 buys online grocery platform Szopi
Szopi's founders join Supermercato24's business development and operations division